Hjem › Tripelnegativ brystkreft › Arizona › Scottsdale
Kliniske studier for Tripelnegativ brystkreft i Scottsdale, AZ
7 studier for Tripelnegativ brystkreft søker deltakere på steder i og rundt Scottsdale (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors
RekruttererFase 1
- HonorHealth Research Institute, Scottsdale
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
RekruttererFase 1
- HonorHealth, Scottsdale
Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer
RekruttererFase 2
- Mayo Clinic in Arizona, Scottsdale
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
RekruttererFase 2
- Mayo Clinic - Scottsdale, Scottsdale
Phase 1/2 Study of Intratumoral Injection of STX-001 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab
RekruttererFase 1/2
- HonorHealth Research and Innovation Institute, Scottsdale
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
RekruttererFase 1/2
- HonorHealth Research Institute, Scottsdale
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
RekruttererFase 1
- HonorHealth Research Institute, Scottsdale
Tripelnegativ brystkreft-studier i andre byer
- Houston, TX42 studier
- New York City, NY31 studier
- Nashville, TN28 studier
- Los Angeles, CA27 studier
- Boston, MA26 studier
- San Antonio, TX23 studier
- St. Louis, MO21 studier
- Arlington, VA20 studier
- Atlanta, GA20 studier
- Dallas, TX18 studier
- Chicago, IL16 studier
- Columbus, OH16 studier
Andre studier i Scottsdale
- Brystkreft18 studier
- Kreft (alle typer)18 studier
- Metastatisk kreft17 studier
- Prostatakreft17 studier
- Kolorektal kreft16 studier
- Ikke-småcellet lungekreft15 studier
- Pankreaskreft13 studier
- Melanom10 studier
- Ulcerøs kolitt8 studier
- Lungekreft8 studier
- Leverkreft (hepatocellulært karcinom)7 studier
- Alzheimers sykdom7 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.